Low serum thyrotropin is associated with high plasma fibrinogen
Abstract
BACKGROUND: Elevated plasma fibrinogen levels are associated with an increased risk of cardiovascular events. Decreased serum TSH predicts vascular mortality, which hypothetically could be explained in part by alterations in the blood coagulation system. OBJECTIVE: The objective of this study was to investigate the association between thyroid function and plasma fibrinogen levels in a general population. DESIGN: The population-based Study of Health in Pomerania was performed in a previously iodine-deficient area in Germany, including 4310 subjects, aged 20-79 yr. Data for 3804 individuals without thyroid disease were analyzed. Analysis revealed an association between thyroid function status and plasma fibrinogen concentration. RESULTS: Elevated fibrinogen levels (>3.25 g/liter) were observed in 14 subjects with increased serum TSH levels (32.6%), 973 euthyroid subjects (28.9%), 158 subjects with decreased serum TSH levels (40.7%), and six individuals with overt hyperthyroidism (54.4%). Logistic regression analysis revealed decreased serum TSH as an independent risk factor for elevated fibrinogen levels (odds ratio, 1.42; 95% confidence interval, 1.12-1.80). CONCLUSIONS: Thyroid function is associated with plasma fibrinogen. Decreased serum TSH is an independent risk factor for elevated plasma fibrinogen levels as a possible explanation for the high cardiovascular mortality among affected subjects.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Overt and subclinical hyperthyroidism are associated with increased markers of thrombogenesis, including fibrinogen and factor X levels.
“Overt and SHyper have been associated with increased markers of thrombogenesis (fibrinogen and factor X levels) (58,59).”
From Thyroid Hormones and Cardiovascular Function and Diseases (2018) · cites this paper as [58]
Cites
Hollowell, J. G., Staehling, N. W., Flanders, W. D., Hannon, W. H., Gunter, E. W., Spencer, C. A., & Braverman, L. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.489 · Cited by 4,279 · see citing works
Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens
Clauss, A. (2009) · Acta Haematologica · doi:10.1159/000205234 · Cited by 3,239 · see citing works
Subclinical Thyroid Disease: Scientific Review and Guidelines for Diagnosis and Management
Surks, M. I., Ortiz, E., Daniels, G. H., Sawin, C. T., Col, N. F., Cobin, R. H., Franklyn, J. A., Hershman, J. M., Burman, K. D., Denke, M. A., et al. (2004) · JAMA · doi:10.1001/jama.291.2.228 · Cited by 1,800 · see citing works
Low Serum Thyrotropin Concentrations as a Risk Factor for Atrial Fibrillation in Older Persons
Sawin, C. T., Geller, A., Wolf, P. A., Belanger, A. J., Baker, E., Bacharach, P., Wilson, P., Benjamin, E. J., & D'Agostino, R. B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311901 · Cited by 1,259 · see citing works
YARNELL, J. W. G., Baker, I. A., Sweetnam, P. M., Bainton, D., O'Brien, J. R., WHITEHEAD, P. J., & Elwood, P. C. (1991) · Circulation · doi:10.1161/01.cir.83.3.836 · Cited by 915 · see citing works
Parle, J. V., Maisonneuve, P., Sheppard, M. C., Boyle, P., & Franklyn, J. A. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06067-6 · Cited by 669 · see citing works
Kannel, W. B., D’Agostino, R. B., & Belanger, A. J. (1987) · American Heart Journal · doi:10.1016/0002-8703(87)90063-9 · Cited by 466 · see citing works
Effects of Subclinical Thyroid Dysfunction on the Heart
Biondi, B., Palmieri, E. A., Lombardi, G., & Fazio, S. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-11-200212030-00011 · Cited by 443 · see citing works
Gharib, H., Tuttle, R. M., Baskin, H. J., Fish, L. H., Singer, P. A., & McDermott, M. T. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1231 · Cited by 394 · see citing works
Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors
FOLSOM, A., WU, K., DAVIS, C., CONLAN, M., SORLIE, P., & SZKLO, M. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90167-2 · Cited by 321 · see citing works
Thyroid Function and Carotid Wall Thickness
Völzke, H., Robinson, D. M., Schminke, U., Lüdemann, J., Rettig, R., Felix, S. B., Kessler, C., John, U., & Meng, W. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031028 · Cited by 151 · see citing works
Self-citationRosengren, A., Wilhelmsen, L., Welin, L., Tsipogianni, A., Teger‐Nilsson, A. ‐., & Wedel, H. (1990) · BMJ · doi:10.1136/bmj.300.6725.634 · Cited by 148 · see citing works
Blood coagulation and fibrinolysis in patients with hyperthyroidism
Erem, C., Ersöz, H. Ö., Karti, S. S., Ükinç, K., Hacıhasanoğlu, A., Değer, O., & Telatar, M. (2002) · Journal of Endocrinological Investigation · doi:10.1007/bf03344016 · Cited by 142 · see citing works
The Association of Thyroid Function with Cardiac Mass and Left Ventricular Hypertrophy
Dörr, M., Wolff, B., Robinson, D. M., John, U., Lüdemann, J., Meng, W., Felix, S. B., & Völzke, H. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1554 · Cited by 140 · see citing works
Self-citationKockx, M., Gervois, P. P., Poulain, P., Derudas, B., Peters, J. M., Gonzalez, F. J., Princen, H. M. G., Kooistra, T., & Staels, B. (1999) · Blood · doi:10.1182/blood.v93.9.2991 · Cited by 139 · see citing works
Thyroid Hormone Receptor-Dependent Transcriptional Regulation of Fibrinogen and Coagulation Proteins
Shih, C., Chen, S. L., Yen, C.-C., Huang, Y., Chen, C.-D., Lee, Y., & Lin, K. (2004) · Endocrinology · doi:10.1210/en.2003-1372 · Cited by 114 · see citing works
Burggraaf, J., Lalezari, S., EMEIS, J. J., Vischer, U. M., Meyer, P., Pijl, H., & Cohen, A. F. (2001) · Thyroid · doi:10.1089/105072501300042820 · Cited by 108 · see citing works
Thyrotoxicosis, atrial fibrillation, and embolism, revisited
Presti, C. F., & Hart, R. G. (1989) · American Heart Journal · doi:10.1016/0002-8703(89)90642-x · Cited by 103 · see citing works
Coagulation disorders in thyroid diseases
Hofbauer, L. C., & Heufelder, A. E. (1997) · European Journal of Endocrinology · doi:10.1530/eje.0.1360001 · Cited by 95 · see citing works
Is Thyroid Hormone Suppression Therapy Prothrombotic?
Horne, M. K., Singh, K. K., Rosenfeld, K. G., WESLEY, R. A., Skarulis, M. C., Merryman, P. K., Cullinane, A., Costello, R., Patterson, A., Eggerman, T. L., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0536 · Cited by 66 · see citing works
Plasma protein regulation by thyroid hormone
Lin, K., Lee, H. Y., Ch, S., Cc, Y., Chen, S., Rc, Y., & Cs, W. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1790367 · Cited by 61 · see citing works
Li, Chen, Tan, Wang, Liang, & Sun (1998) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1998.00381.x · Cited by 56 · see citing works
Relationship between thyroid hormones and fibrinogen levels
Chadarévian, R., Bruckert, É., Giral, P., et al. (1999) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-199912000-00005 · Cited by 52 · see citing works
Kalaria, V. G., Zaręba, W., Moss, A. J., et al. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)00785-2 · Cited by 39 · see citing works
Fr, O. (1962) · The Lancet · doi:10.1016/s0140-6736(62)92701-0 · Cited by 17 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
The Clinical Significance of Subclinical Thyroid Dysfunction
Biondi, B., & Cooper, D. S. (2008) · Endocrine Reviews · doi:10.1210/er.2006-0043 · Cited by 1,418 · see citing works
Cooper, D. S., & Biondi, B. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60276-6 · Cited by 1,039 · see citing works
Thyroid hormones and cardiovascular disease
Jabbar, A., Pingitore, A., Pearce, S. H. S., Zaman, A., Iervasi, G., & Razvi, S. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.174 · Cited by 729 · see citing works
Thyroid Hormones and Cardiovascular Function and Diseases
Razvi, S., Jabbar, A., Pingitore, A., Danzi, S., Biondi, B., Klein, I., Peeters, R., Zaman, A., & Iervasi, G. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.02.045 · Cited by 515 · see citing works
Razvi, S., Shakoor, A., Vanderpump, M., Weaver, J. U., & Pearce, S. H. S. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0167 · Cited by 330 · see citing works
Cardiovascular involvement in patients with different causes of hyperthyroidism
Biondi, B., & Kahaly, G. J. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.105 · Cited by 230 · see citing works
The influence of thyroid function on the coagulation system and its clinical consequences
Elbers, L. P. B., Fliers, E., & Cannegieter, S. C. (2018) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13970 · Cited by 123 · see citing works
Völzke, H., Schwahn, C., Wallaschofski, H., & Dörr, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0179 · Cited by 120 · see citing works
Self-citationFranchini, M., Lippi, G., & Targher, G. (2011) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029610364521 · Cited by 71 · see citing works
Hooper, J. M. W., Stuijver, D. J. F., Orme, S. M., van Zaane, B., Hess, K., Gerdes, V. E., Phoenix, F., Rice, P., Smith, K. A., Alzahrani, S. H., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2894 · Cited by 54 · see citing works
Abdel-Moneim, A., Gaber, A. M., Gouda, S., Osama, A., Othman, S. I., & Allam, G. (2020) · Hormones · doi:10.1007/s42000-020-00208-8 · Cited by 45 · see citing works
Lupoli, R., Di Minno, M. N. D., Tortora, A., Scaravilli, A., Cacciapuoti, M., Barba, L., Di Minno, A., Ambrosino, P., Lupoli, G. A., & Lupoli, G. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1726 · Cited by 26 · see citing works
Thyroid function and cardiovascular disease: the mediating role of coagulation factors.
Bano, A., Chaker, L., de Maat, M. P. M., Atiq, F., Kavousi, M., Franco, O. H., Mattace-Raso, F. U. S., Leebeek, F. W. G., & Peeters, R. P. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00072 · Cited by 25 · see citing works
Levothyroxine (LT<sub>4</sub>) suppression treatment for benign thyroid nodules alters coagulation
Demir, T., Akinci, B., Comlekci, A., Karaoglu, O., Ozcan, M. A., Yener, S., Yuksel, F., Secil, M., & Yesil, S. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03497.x · Cited by 13 · see citing works
Akinci, B., Demir, T., Comlekci, A., Yener, S., Ozcan, M. A., Karaoglu, O., Yuksel, F., Secil, M., & Yesil, S. (2011) · Medical Principles and Practice · doi:10.1159/000322074 · Cited by 7 · see citing works
- Authors
- Dörr, M., Robinson, D. M., Wallaschofski, H., Schwahn, C., John, U., Felix, S. B., & Völzke, H.
- Affiliations
- Departments of Internal Medicine B (M.D., D.M.R., S.B.F.), D-17487 Greifswald, Germany.
- Universitätsmedizin Greifswald (DE)
- Universität Greifswald (DE)
- Institute of Epidemiology and Social Medicine (U.J., H.V.), Ernst Moritz Arndt University, D-17487 Greifswald, Germany.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2006-02-01
- Volume
- 91
- Issue
- 2
- Pages
- 530-534
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2105216713
- Cited by
- 73
- References
- 25
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 5 · 2022: 5 · 2021: 2 · 2020: 5 · 2019: 4 · 2018: 5 · 2017: 5 · 2016: 4 · 2015: 4 · 2014: 4 · 2013: 1 · 2012: 6
- FWCI
- 3.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Blood properties and coagulation
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- thyroid-stimulating hormone, fibrinogen, thyroid function, hyperthyroidism, cardiovascular risk, coagulation, iodine deficiency, cardiovascular mortality, Study of Health in Pomerania
- MeSH terms
- Adult, Aged, Female, Fibrinogen, Humans, Male, Middle Aged, Thyroid Gland, Thyrotropin, Thyroxine, Triiodothyronine, Multivariate Analysis, Logistic Models
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review